Magnetic Resonance Imaging and [ 18F ]‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography‐Guided Therapy Improves Survival in Upper Aerodigestive Tract NK /T‐Cell Lymphoma, Nasal Type: A Prospective Cohort Study
Head & Neck · 2025
DOI: 10.1002/hed.28137 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Head & Neck, 2025. Verfasst von Quanguang Ren und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Ce…. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Lymphoma, Extranodal NK-T-Cell, Magnetic Resonance Imaging, Nose Neoplasms. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Youth Program, Natural Science Foundation of Hubei Province, People's Republic of China, National Natural Science Foundation of China, Hubei Provincial Natural Science Foundation.
Abstract (Originalsprache)
Background
To investigate the value of pretreatment nasopharyngeal and neck magnetic resonance imaging (NN‐MRI) combined with positron emission tomography (PET)/CT‐guided therapy for improving survival in upper aerodigestive tract NK/T‐cell lymphoma (UADT‐NKTL) patients.
Methods
We performed a prospective cohort study including 171 untreated patients histologically diagnosed with UADT‐NKTL, of whom 71 patients received PET/CT combined with NN‐MRI and the other 100 patients received PET/CT alone. The clinical stage of every patient was classified according to the Ann Arbor and TNM staging systems. Clinical stage, target volume delineation, and survival were evaluated and compared for PET/CT with and without NN‐MRI.
Results
By detecting additional local lesions, NN ‐ MRI upgraded the clinical stages on the basis of the Ann Arbor staging system and TNM staging system compared to the results of PET / CT (9/71, p = 0.011; 11/71, p = 0.019, respectively), which revised the target volume delineation of radiotherapy (9/71) in the PET / CT ‐ MRI group. Compared with those in the PET / CT group, 3‐year local recurrence‐free survival was prolonged in the PET / CT ‐ MRI group (100% vs. 74.9%; p < 0.001), and 3‐year overall survival and progression‐free survival were better in the PET / CT ‐ MRI group (84.5% vs. 76.3%, p = 0.04 and 78.3% vs. 67.3%, p = 0.03, respectively).
Conclusion
NN‐MRI and PET/CT‐guided therapy could complementarily assist in optimizing the determination of clinical stage and target delineation, which could improve the prognosis of UADT‐NKTL patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
- Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
- Department of Medical Oncology, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.
- Department of Oncology, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.
- Department of Radiation Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.
ORCID-Profile: Quanguang Ren, Ying Huang, Qingqing Cai
Förderung
- Youth Program, Natural Science Foundation of Hubei Province, People's Republic of China
- National Natural Science Foundation of China
- Hubei Provincial Natural Science Foundation
- Natural Science Foundation of Hubei Province
Zitieren
APA
Ren, Q., Cui, Y., Huang, H., Li, X., Hong, H., Wang, Z., Fang, X., Guo, C., Yao, Y., Chen, Z., Huang, Y., Li, Z., Cai, Q., Tian, Y., Wang, H., Lin, X., Fan, W., Zheng, L., Lin, S., …, & Lin, T. (2025). Magnetic Resonance Imaging and [ 18F ]‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography‐Guided Therapy Improves Survival in Upper Aerodigestive Tract NK /T‐Cell Lymphoma, Nasal Type: A Prospective Cohort Study. Head & Neck. https://doi.org/10.1002/hed.28137
Vancouver
Ren Q, Cui Y, Huang H, Li X, Hong H, Wang Z, et al. Magnetic Resonance Imaging and [ 18F ]‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography‐Guided Therapy Improves Survival in Upper Aerodigestive Tract NK /T‐Cell Lymphoma, Nasal Type: A Prospective Cohort Study. Head & Neck. 2025. doi:10.1002/hed.28137
BibTeX
@article{Ren2025,
author = {Ren, Quanguang and Cui, Yue and Huang, He and Li, Xueying and Hong, Huangming and Wang, Zhao and Fang, Xiaojie and Guo, Chengcheng and Yao, Yuyi and Chen, Zegeng and Huang, Ying and Li, Zhiming and Cai, Qingqing and Tian, Ying and Wang, Hanyu and Lin, Xiaoping and Fan, Wei and Zheng, Lie and Lin, Suxia and Guo, Ying and Lin, Tongyu},
title = {Magnetic Resonance Imaging and [ 18F ]‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography‐Guided Therapy Improves Survival in Upper Aerodigestive Tract NK /T‐Cell Lymphoma, Nasal Type: A Prospective Cohort Study},
journal = {Head & Neck},
year = {2025},
doi = {10.1002/hed.28137}
}
EUVIMED